With the vaccine now being fully approved, that means we could see more instances of required vaccinations in workplaces, businesses and schools across Central New York and in other cities, states, and continents.
The 'Phase 3' portion of the trial began last week. That's where researchers work to determine whether a vaccine is capable of fighting off the intended disease.